Lloyd G. Cantley, MD, is the C. N. H. Long Professor of Medicine in Nephrology and Professor of Cellular and Molecular Physiology at Yale School of Medicine. He serves as Vice Chair for Research and Co-Director of Education at the Yale Center for Clinical Investigation (YCCI). His primary appointments are in the Department of Internal Medicine (Nephrology) and the Department of Cellular & Molecular Physiology, and he is affiliated with numerous research programs including the Yale Cancer Center, Yale Stem Cell Center, and the Program in Translational Biomedicine (PTB). Research Interests: Dr. Cantley's laboratory investigates the fundamental mechanisms of renal tubule development, homeostasis, and repair following injury. His work focuses on epithelial cell adhesion, migration, and tubulogenesis, particularly in response to growth factors like Hepatocyte Growth Factor. A major emphasis is on understanding the role of MAPK and PI3-kinase signaling pathways in cell morphogenesis. His research has significantly advanced knowledge of the innate immune response in kidney injury, identifying distinct roles for macrophage subsets in promoting both tubular cell death and subsequent repair. His recent work has expanded to human acute and chronic kidney disease using advanced imaging techniques like Imaging Mass Cytometry. Research Trends: His recent publications (2022-2025) demonstrate a strong, consistent focus on translating basic mechanisms of kidney repair into human disease. There is a clear trend of integrating advanced technologies, particularly Imaging Mass Cytometry, to define cellular identities and interactions in human kidney biopsies from patients with AKI, CKD, and glomerulonephritis. His work bridges molecular biology, immunology, and clinical nephrology, with a recurring theme of identifying signaling pathways (like VCAM-1 and ADAMTS1) that could be therapeutic targets for preventing the progression from acute injury to chronic disease. Scientific Awards and Grants: No specific awards are listed in the provided text. His research is supported by major national organizations including the National Center for Advancing Translational Sciences (NCATS), the American Heart Association (AHA), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the Department of Defense (DoD). Advising and Leadership: Dr. Cantley leads the Cantley Lab, which is integrated into the Graduate Program in Cellular and Molecular Physiology and the Yale Combined Program in the Biological and Biomedical Sciences (BBS). He plays a key leadership role in academic medicine as Co-Director of Education at YCCI, indicating a significant commitment to training the next generation of clinical investigators. While specific student names are not listed, his lab's active publication record suggests he mentors graduate students, postdoctoral fellows, and clinical researchers. Laboratories and Teams: Dr. Cantley directs the Cantley Lab , which is a central hub for his research on kidney injury and repair. His work is highly collaborative, as evidenced by his frequent co-authorship with Yale colleagues like Gilbert Moeckel, Leyuan Xu, Dennis G. Moledina, and F. Perry Wilson. His lab is a key member of the Liver Center and the Nephrology Program at Yale, and his research is supported by institutional cores such as the Yale Center for Biomedical Data Science.



